Overcoming Challenges in Skin Microbiome Research

from Sampling to Analysis

Our microbiome processing and sequencing experts, Daryl Gohl, Ph.D. and Brice LeFrancois, Ph.D., presented an overview of DNA Genotek’s novel OMNIgene®•SKIN sampling device for microbial DNA and how to overcome the most common challenges in skin microbiome sampling and data analysis. 

Behind the Data with Dan Knights, Ph.D. and Joe Petrosino, Ph.D.

Live Discussion and Q&A

Dr. Dan Knights and Dr. Joe Petrosino, both leading pioneers in the microbiome industry, discussed best practices for microbiome analysis, including longitudinal studies with shotgun metagenomics and real-use cases for WGS and 16S. Watch this webinar and learn from their combined experience how to ensure insightful data outcomes from early research pilots to clinical practice and precision medicine.

Viral Metagenomics and the Use of Standards

From Biology to Clinical Applications

The interactions between viruses and the human microbiome are being revealed with the advent of metagenomics. New sequencing technologies and analysis tools are expanding the knowledge and applications of viral communities in the microbiome. Translating into clinical and other application, viral standards and controls are becoming increasingly important as researchers look to make meaningful cross-study comparisons, assess biases, and plan viral metagenomic pipelines.

De-Risking Microbiome Research and Clinical Discoveries

Robust At-Home Methods for Sample Collection, Storage, and Transport

Variables in microbiome experiments can cause unwanted variations in downstream analysis and results. DNA Genotek and Diversigen have come together to present ways to generate more stable and reproducible data using at-home methods for sample collection. Sample collection, storage, and transport are high risk steps that can introduce biases and inaccuracies; learn to design your study with minimal sample risk.

Viral Metagenomics Identifying the Needles in the Haystack

& Unlocking Opportunities for Discovery

Microbiome researchers continue to face hurdles at each stage of their workflow and, although, the microbiome continus to provide valuable insights into human health and disease, there are many questions left to answer. Learn about current gaps in research workflows and future trends in microbiome research while learn about the challenges and solutions in the development and application of microbiome standards.

Leveraging Diversigen's Bioinformatics Platforms

for CAZyme Characterization and Discovery

Carbohydrate Active Enzymes (CAZymes), are involved critical carbohydrate metabolism activities like anabolism and catabolisms. CAZymes play a critical roles in human digestion and microbiome regulation – for example, dysregulation of CAZymes can cause dysbiosis. Carbohydrate metabolism also affects agriculture and biofuel production. As the role of CAZymes continues to be understood Diversigen has created a new platform to enhance CAZyme discovery and help expand upon previous methods of characterization that faced limitations and challenges.

Ready to get started?

Diversigen provides services and generates data for research purposes only.  Not all services are available in all regions.